Viewing Study NCT05668403

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2026-05-25 @ 10:27 AM
Study NCT ID: NCT05668403
Status: RECRUITING
Last Update Posted: 2025-02-10
First Post: 2022-12-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Membranous Nephropathy View
Keywords: